CClinicalTrials.gg
Enrolling by invitationNCT07479810PACUPUpdated Mar 18, 2026

Chronic Diseases in Primary Care

An interventional study of Proactive Intervention in Chronic Disease, sponsored by Universita di Verona. Enrolling by invitation at 1 site in Italy. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-03-18.

Sponsored by Universita di Verona · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
65 Years and older
Sex
All
01

Study summary

This quasi-experimental study aims to assess if a nurse-led proactive intervention can enhance self-care and reduce hospitalizations or accesses to emergency department visits in chronically ill adults over 65 years old.

The questions that it seeks to answer are the following:

  1. Can a structured, proactive nurse-led intervention reduce hospitalizations and access to emergency departments?
  2. Can this intervention improve self-care, medication adherence, and the overall quality of life?

To assess its effectiveness, researchers will evaluate health outcomes before and after carrying out the intervention.

Participants will receive an initial assessment to identify specific educational needs. To enhance self-care and symptom management, patients will participate in at least three scheduled follow-up sessions (via phone call or face-to-face) during the following six months. They will also complete questionnaires assessing lifestyle quality, medication adherence, and self-care abilities.

Read the detailed description

The study aims to evaluate the effectiveness of managing people with chronic diseases through structured patient education, proactive healthcare, and prevention programs in primary care.

The intervention will be carried out in the outpatient setting and delivered by family and community nurses working in a Community Health Home, located in a rural district in northern Italy.

The quasi-experimental study takes place from September 2023 to September 2025.

  • Population - All patients meeting the following inclusion criteria will be included: a) diagnosed with at least one non-oncological chronic condition, b) aged over 65 years, and c) assigned to general practitioners in the district of reference of the Community Health Home. Potential participants will be referred by general practitioners, social workers, or other professionals from home care, community, and transitional care services to family and community nurses (hereafter, nurses). Nurses will collect the informed written consent to participate in the study. Patients will be recruited through a consecutive sampling. It wasn't possible to perform an a priori power analysis because there are no available data on the chosen primary endpoint.
  • Educational Intervention - The intervention will involve nurses proactively caring for patients with chronic conditions based on the Chronic Care Model approach and the Middle Range Theory of self-care in chronic disease, focusing on behavior change, engagement and empowerment, self-care and symptom perception, and health promotion planning strategies.

This process will be initiated through a phone call, during which the service will be introduced, and an appointment will be scheduled for either an outpatient or home nursing visit, depending on the patient's ability to access the Community Health Home. Following the initial structured assessment interview, patients will receive structured follow-up care with at least three contacts over six months. The frequency of these contacts will be increased at the nurse's discretion in cases of poor self-care ability or multiple educational needs identified during the initial interview. The follow-up will consist of in-person visits alternated with telephone follow-ups, focusing on self-care skill development and clinical monitoring.

Nurses will be trained on the study by a researcher in three meetings of two hours to ensure that all nurses carry out the intervention uniformly and reliably.

-Therapeutic education-

To assess educational needs, on the first interview, nurses will collect:

i) Socio-demographic data, as age, sex, informal caregiver(s) of reference, and cohabitation status; ii) Priority needs of the patients and informal caregivers through open-ended questions.

iii) Data from clinical conditions, as weight, height, vital signs, diseases, medications, blood tests, and medical exams, and civil disability status.

At the end, nurses will perform a structured assessment of social and educational needs in terms of:

  • lifestyle (level of physical activity, alcohol consumption, sleeping quality, smoking habit);
  • self-care skills (Patient Activation Measure questionnaire);
  • risk of clinical-social frailty (Sunfrail questionnaire).

If any concerns or issues emerge, other questionnaires will be used for specific problems. All questionnaires will be used in their validated Italian versions and compiled into a pre-filled Excel file for each patient, created by the researchers.

These elements will be pre-filled based on data inputted by nurses and finalized manually. All information will be incorporated into an educational plan, which will be provided to the patient in written form.

Throughout all interviews, four communication approaches will be implemented:

  1. Teach-back, to assess an individual's understanding of newly acquired information;
  2. Motivational Interviewing, a counseling approach that facilitates collaborative dialogues to elicit the individual's intrinsic reasons for change, commitment.
  3. Sharing Evidence Routine for a Person-centred Plan for Action (SHERPA model), a structured shared decision-making approach;
  4. Family interviews according to the Calgary Family Assessment and Intervention Models, designed to support families as a unit, strengthening resilience and self-care.

    • Outcomes - The primary clinical outcome will be a composite outcome, assessed at 6 and 12 months: access to the emergency department and/or hospitalization.

Secondary outcomes include quality of care and medication adherence, and self-care abilities. These will be assessed with Patient-Reported Experience Measures (PREMs), questionnaires, and other indicators related to the process (number of visits, number of prescriptions, number of activated services).

-Data Collection- Nurses' charts (Excel files) and hospital and pharmaceutical databases will be used by authorised members to extract data.

- Statistical Analysis- Descriptive statistics will be employed by researchers to summarize socio-demographic characteristics. The Wilcoxon signed-rank test and McNemar's test will be used to compare pre-post-intervention outcomes.

Primary and secondary outcomes will be analyzed according to the intention-to-treat principle at the level of individual participants. Changes in repeated measures over time will be evaluated, with adjustments for baseline confounders. To further increase the transparency of results, researchers will evaluate to perform a sensitivity analysis. Cost analysis will be considered, taking into account human resources involved, materials, technologies, and savings from avoided hospitalizations and emergency care.

02

Conditions studied

  • Chronic Disease

Browse trials for

Keywords

  • primary care
  • community nursing
  • chronic deseases
  • patient education
03

In context

Chronic Disease

990 studies on the registry are indexed under Chronic Disease; 178 are open to participants now.

This study's planned enrollment of 100 is below the median of 120 across 722 interventional studies indexed under Chronic Disease.

Browse Chronic Disease studies →

Lead sponsor

Universita di Verona is the lead sponsor of 122 studies on the registry; 26 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosed with at least one non-oncological chronic condition;
  • Aged over 65 years;
  • Assigned to general practitioners in the district of reference of the Community Health Home.

Exclusion criteria

Exclusion criteria:

  • Life expectancy of less than 12 months, as assessed by the general practitioner;
  • Having more than one home access a week of intensive home care.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Other
    Intervention

    Single arm

    Other: Proactive Intervention

Interventions

  • OtherProactive Intervention

    The educational program will be carried out as a structured intervention, aiming to actively involve patients in their own healthcare pathway, promoting changes in behavior and self-care. The first act will consist of a double-level assessment, first having nurses collect data to assess the educational needs, then delving into a structured assessment of social and educational needs from lifestyle, self-care, medication adherence, and frailty risk. After that, four communication approaches will be implemented to enhance educational effectiveness: teach-back, motivational interviewing, the SHERPA model, and Calgary Family Interviews.

06

What researchers measure

Primary outcomes

  1. Composite Outcome - access to the emergency department or hospitalization

    The number of patients with at least one event between: * access to the emergency department for pathological causes related to the chronic disease; * hospitalization for related pathological causes. Data will be collected from hospital integrated databases (Atlante, HR suite) from authorized employed healthcare professionals.

    Time frame: 6 and 12 months pre-post

Secondary outcomes

  1. Result endpoint: Medication adherence.

    Within the reference period, each patient medication adherence will be calculated for each chronic drug therapy by comparing the theoretical days of prescription coverage with the effective period (in days) elapsed between drug prescriptions. % of medication adherence = \[(n. of pills inside the box \* drug dosage)/ daily dose\] / days elapsing between the prescriptions.

    Time frame: 6 and 12 months after the intervention

  2. Result endpoint: Self-care ability

    The outcome will be assessed through the Patient Activation Measure (PAM), a survey validated also initalian (local language).

    Time frame: 6 and 12 months after the intervention

  3. Result endpoint: Quality of received care

    The quality of recived care will be assessed via a Patient Reported Experience Measures (PREMsT), already adopted from the local health authority (ULSS 8 Berica). Questions will be asking patients opinions about the visit experience (relationship with the healthcare professional, waiting times) and about community healthcare assistance (management of health and care), giving also the chance to leave comments and suggestions.

    Time frame: 6 and 12 months after the intervention

Other outcomes

  1. Process evaluations: periodic use of nursing service

    Number of users with at least 3 nursing visits within the reference period.

    Time frame: 12 months after the intervention

  2. Process evaluation: service utilization for each user

    Number of nursing visits received for each user within the reference period

    Time frame: 12 months after the intervention

  3. Process evaluations: GP visits

    Number of medical visits by the general practitioner for each user, within the reference period.

    Time frame: 12 months after the intervention

  4. Process evaluations: prescriptions of aids and devices

    Rate of users with new prescriptions of aids or devices requested within the reference period.

    Time frame: 12 months after the intervention

  5. Process evaluations: family assessment

    Number of users that recived structured assessment interviews for families within the reference period.

    Time frame: 12 months after the interventions

  6. Process evaluations: nurse visits at home

    Number of users that recieved at least one nuse visit at home within the reference period.

    Time frame: 12 months after the intervention

  7. Process evaluations: activation of healthcare services

    Number of services activated per person: physiotherapist, palliative care, social worker, etc.

    Time frame: 12 months after the intervention

  8. Process evaluations: relapses of desease

    Rate of users reported to the general practitioner for suspected exacerbation of chronic pathology within 12 months after the intervention.

    Time frame: 12 months after the intervention

07

Study locations

1 site
  • Casa della Comunità di Lonigo
    Lonigo, Vicenza, Italy
08

References and documents

Individual participant data

Plan to share: Yes — Only IPD used in the results publication

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07479810
Lead sponsor
Universita di Verona
Responsible party
Federica Canzan (Associate Professor, Universita di Verona) — Principal investigator
First posted
Mar 18, 2026
Start date
Nov 1, 2024
Primary completion
Jan 31, 2025
Completion
Sep 30, 2026 (estimated)
Last update
Mar 18, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion